000			01941 a2200469 4500
005			20250514020725.0
264		0	_c20020124
008			200201s 0 0 eng d
022			_a0363-6135
024	7		_a10.1152/ajpheart.2002.282.1.H194 _2doi
040			_aNLM _beng _cNLM
100	1		_aMarchand, Geneviève S
245	0	0	_aBlockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors. _h[electronic resource]
260			_bAmerican journal of physiology. Heart and circulatory physiology _cJan 2002
300			_aH194-204 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aEndothelial Growth Factors _xantagonists & inhibitors
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aGenetic Therapy
650	0	4	_aLymphokines _xantagonists & inhibitors
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeovascularization, Pathologic _xprevention & control
650	0	4	_aOligonucleotides, Antisense _xpharmacology
650	0	4	_aProto-Oncogene Proteins _xdrug effects
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aReceptor Protein-Tyrosine Kinases _xdrug effects
650	0	4	_aReceptors, Growth Factor _xdrug effects
650	0	4	_aReceptors, Vascular Endothelial Growth Factor
650	0	4	_aTime Factors
650	0	4	_aTranscription, Genetic
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factor Receptor-1
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aNoiseux, Nicolas
700	1		_aTanguay, Jean-François
700	1		_aSirois, Martin G
773	0		_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 282 _gno. 1 _gp. H194-204
856	4	0	_uhttps://doi.org/10.1152/ajpheart.2002.282.1.H194 _zAvailable from publisher's website
999			_c11660869 _d11660869